STORM Therapeutics
About STORM Therapeutics
STORM Therapeutics is a Cambridge, UK-based biotechnology company focused on discovering and developing small molecule therapies that target RNA modifying enzymes involved in RNA epigenetics. The company aims to treat cancer and other diseases by inhibiting RNA modifications that drive cellular processes. It positions itself as a clinical stage biotech developing first-in-class inhibitors with a research emphasis on RNA-modifying enzymes as therapeutic targets.
Recent News
No recent news for this company.
Recent Deals
No recent deals for this company.